NCT07036848Recruiting
Efficacy and Safety of Surgical Treatment for Type IVa CBD
The Efficacy and Safety of Surgical Treatment in Type IVa Congenital Biliary Dilation: A Multi-center Cohort Study
Source: ClinicalTrials.gov · Last updated 17 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for IVa biliary dilatation (BD). Based on this cohort, the study seeks to compare the perioperative risks, long-term outcomes, and quality of life of type IVa BD following surgical treatment, to establish standardized surgical treatment strategies for type IVa BD.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 17 Jun 2025
- Start date
- 14 Jul 2025
- Primary completion date
- 14 Jul 2025
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- NCT number
- NCT07036848
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 14 Jul 2025 to the primary completion date, 14 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- With non-relevant surgical interventions
Other
- With abnormal intrapancreatic bile duct
- Inappropriate Roux-loop length (outside the range of 40-60 cm for adults and 15-30 cm for children)
- Pathologically confirmed carcinogenesis
- Unresolved choledocholithiasis, bile duct stenosis, and Intrahepatic bile duct stones during the procedure.
- Unavailable follow-up information.
Who the study is looking for
- Patients who have been diagnosed with Todani type IVa BD.
- Patients aged between 0 and 80 years old, regardless of gender.
- First-time receipt of surgery.
Age in the registry: - to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Tsinghua Changgung Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.